Inhibiting MDM2 oncogene expression as a novel approach to human cancer therapy.

被引：0
|
作者：
Wang, H
Agrawal, S
Zhang, R
机构：
[1] Hybridon Inc, Milford, MA USA
[2] Univ Alabama, Div Clin Pharmacol, Birmingham, AL 35294 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2000年 / 67卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OIIA4
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [21] Overexpression of the MDM2 oncogene in leukemia and lymphoma
    Watanabe, T
    Ichikawa, A
    Saito, H
    Hotta, T
    LEUKEMIA & LYMPHOMA, 1996, 21 (5-6) : 391 - 397
  • [22] Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy
    Jiang-Jiang Qin
    Sushanta Sarkar
    Sukesh Voruganti
    Rajesh Agarwal
    Wei Wang
    Ruiwen Zhang
    The Journal of Biomedical Research, 2016, 30 (04) : 322 - 333
  • [23] ENHANCED TRANSLATION - A NOVEL MECHANISM OF MDM2 ONCOGENE OVEREXPRESSION IDENTIFIED IN HUMAN TUMOR-CELLS
    LANDERS, JE
    HAINES, DS
    STRAUSS, JF
    GEORGE, DL
    ONCOGENE, 1994, 9 (09) : 2745 - 2750
  • [24] Studies on MDM2 oncogene expression and its effect on pancreatic carcinoma cells
    China Medical Abstracts (Internal Medicine), 1996, (04) : 225 - 225
  • [25] Jmjd2c histone demethylase enhances the expression of Mdm2 oncogene
    Ishimura, Akihiko
    Terashima, Minoru
    Kimura, Hiroshi
    Akagi, Keiko
    Suzuki, Yutaka
    Sugano, Sumio
    Suzuki, Takeshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 389 (02) : 366 - 371
  • [26] PTEN and MDM2 inhibitors; Toward a novel pro-senescence therapy approach for patients with cancer.
    Alimonti, A.
    Nardella, C.
    Pavese, I.
    Clohessy, J. G.
    Carracedo, A.
    Trotman, L. C.
    Woscholski, R.
    Cognetti, F.
    Scher, H. I.
    Pandolfi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Applications of the inhibition of Mdm2 function in Cancer Therapy
    Lane, D.
    Brown, C.
    Cheok, C. F.
    Verma, C.
    EJC SUPPLEMENTS, 2010, 8 (07): : 22 - 23
  • [28] Regulation of the mdm2 oncogene by thyroid hormone receptor
    Qi, JS
    Yuan, Y
    Desai-Yajnik, V
    Samuels, HH
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (01) : 864 - 872
  • [29] Haplotype structure and selection of the MDM2 oncogene in humans
    Atwal, Gurinder Singh
    Bond, Gareth L.
    Metsuyanim, Sally
    Papa, Moshe
    Friedman, Eitan
    Distelman-Menachem, Tal
    Ben Asher, Edna
    Lancet, Doron
    Ross, David A.
    Sninsky, John
    White, Tomas J.
    Levine, Arnold J.
    Yarden, Ronit
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (11) : 4524 - 4529
  • [30] Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy
    Li, Qin
    Lozano, Guillermina
    CLINICAL CANCER RESEARCH, 2013, 19 (01) : 34 - 41
12345